表紙:関節痛用注射剤市場- 注射タイプ別、関節タイプ別、エンドユース別&世界予測、2023年~2032年
市場調査レポート
商品コード
1260672

関節痛用注射剤市場- 注射タイプ別、関節タイプ別、エンドユース別&世界予測、2023年~2032年

Joint Pain Injections Market - by Injection type, By Joint type, By End-use & Global Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 180 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
関節痛用注射剤市場- 注射タイプ別、関節タイプ別、エンドユース別&世界予測、2023年~2032年
出版日: 2023年03月23日
発行: Global Market Insights Inc.
ページ情報: 英文 180 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

関節痛用注射剤の市場動向は、世界中で膝関節痛用注射剤の需要が高まっていることから、2032年までに拡大すると予想されています。

膝関節痛の注射は、関節の痛みを治療するための理想的な製品であると考えられています。メディケアサンプルデータベースの最近の評価では、新たに変形性膝関節症と判明した患者の1/3以上が、少なくとも1回の関節内コルチコステロイド注射で治療を受けていることが実証されています。

関節の炎症や痛み、軟部組織の状態を効果的かつ迅速に治療するための関節痛注射の需要の高まりは、2023-2032年の市場見通しをさらに強化すると考えられます。

著名な市場関係者による世界展開や製品の多様化戦略は、業界の成長に好影響を与えることが予想されます。例えば、セイカグ社は台湾でHyLinkを発売しました。この製品は、変形性膝関節症治療用の関節内単回注射用ビスコサプリメントです。精華閣の卓越した架橋技術で作られています。

世界の関節痛用注射剤産業は、注射剤の種類、関節の種類、最終用途、地域に基づいて二分されています。

注射の種類では、血小板リッチプラズマが、痛みや腫れを最適に緩和し、長時間自由に動くことができることから、2032年までかなりの利益を上げると予測されています。ある研究によると、血小板リッチプラズマ注射は、OAに苦しむ患者の痛みの軽減と機能改善において有望な結果を示しています。さらに、この注射は人工膝関節置換術の必要性を遅らせることもできます。このような要因が、今後数年間におけるこの分野の成長見通しを後押しするものと思われます。

関節の種類別では、足首と股関節の関節炎の罹患率が上昇していることから、足首と股関節の分野が大きな牽引力を持つと考えられます。最近の調査によると、足首の変形性関節症は現在、世界人口の1%が罹患しており、その頻度は10万人あたり30件と推定されています。さらに、足首や股関節の関節痛の治療に十分な効果をもたらす関節痛注射の進歩や、この分野の著名企業による新製品の発売は、2023年から2032年にかけての市場成長を潜在的に促進すると考えられます。

基本推定では、クリニックは、低侵襲な外科的処置に対する人々の嗜好の高まりによって、世界の痛み止め注射市場で大きな弾みをつけると予想されます。幅広い整形外科手術が可能であること、手術に先端技術を導入していること、クリニックで高品質のサービスを提供していることなどの重要な要因が、市場の活況に拍車をかけると考えられます。2032年には、この分野の売上は25億米ドルを超えると予測されています。

地域的には、ヘルスケア支出の増加、高齢者人口の増加、OAの急増を背景に、関節痛用注射剤の販売は、今後数年間、欧州で勢いを増すと推定されます。また、整形外科疾患治療へのアクセスを促進するために、さまざまな中央政府が斬新な戦略を採用していることも、この地域の市場成長を補完すると考えられます。

目次

第1章 調査手法

  • 市場の定義
  • 基本推定&ワーキング
  • 予測パラメータ
  • データバリデーション
  • データジョイントの種類
    • 2次データ
      • 有償ジョイントタイプ
      • 未払いジョイントタイプ
    • 1次データ

第2章 エグゼクティブサマリー

第3章 関節痛注射の業界洞察

  • 業界別セグメンテーション
  • 業界の情勢、2018年~2032年版
  • インダストリー・インパクト・ファクター
    • 促進要因
      • 整形外科疾患の普及が進む
      • 技術的な進歩
      • 膝痛用注射剤の需要増
      • 関節の痛みと炎症を和らげる治療効果の高さ
    • 業界の潜在的リスク&課題
      • 関節痛の注射の高額な費用
      • 関節痛注射に伴う副作用について
  • 成長性分析
    • 注射器の種類別
    • ジョイントタイプ別
    • エンドユーズ別
  • COVID-19影響解析
  • ポーター分析
  • 競合情勢、2022年
    • 企業マトリックス分析、2022年
  • PESTEL分析

第4章 関節痛用注射剤市場:注射剤タイプ別

  • 主なセグメント動向
  • ヒアルロン酸注入
  • コルチコステロイド注射
  • 血小板リッチプラズマインジェクション

第5章 関節痛用注射剤市場:関節タイプ別

  • 主なセグメント動向
  • 肩・ひじ
  • 足首・股関節
  • その他

第6章 関節痛用注射剤市場:エンドユーザー別

  • 主なセグメント動向
  • 病院
  • クリニック
  • その他

第7章 関節痛用注射剤市場:地域別

  • 主な地域動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ地域
    • 南アフリカ
    • サウジアラビア
    • UAE

第8章 企業プロファイル

  • Competitive dashboard, 2022
  • Zimmer Biomet
  • Anika Therapeutics, Inc.
  • Bioventus
  • Sanofi
  • Pacira BioSciences(Flexion)
  • OrthogenRx
  • Pfizer
  • Ferring B.V.
  • Lifecore Biomedical
  • Wright Medical Group(Stryker)
  • Stryker
  • 9.12. Emcyte Corporation
  • Arthrex
図表

Data Tables

  • TABLE 1. Global Joint Pain Injections Market, 2018 - 2022 (USD Million)
  • TABLE 2. Global Joint Pain Injections Market, 2023 - 2032 (USD Million)
  • TABLE 3. Global Joint Pain Injections Market, by injection type, 2018 - 2022 (USD Million)
  • TABLE 4. Global Joint Pain Injections Market, by injection type, 2023 - 2032 (USD Million)
  • TABLE 5. Global Joint Pain Injections Market, by joint type, 2018 - 2022 (USD Million)
  • TABLE 6. Global Joint Pain Injections Market, by joint type, 2023 - 2032 (USD Million)
  • TABLE 7. Global Joint Pain Injections Market, by end use, 2018 - 2022 (USD Million)
  • TABLE 8. Global Joint Pain Injections Market, by end use, 2023 - 2032 (USD Million)
  • TABLE 9. Global Joint Pain Injections Market, by region, 2018 - 2022 (USD Million)
  • TABLE 10. Global Joint Pain Injections Market, by region, 2023 - 2032 (USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Hyaluronic Acid Injections size, by region, 2018 - 2022 (USD Million)
  • TABLE 13. Hyaluronic Acid Injections size, by region, 2023 - 2032 (USD Million)
  • TABLE 14. Corticosteroid injection size, by region, 2018 - 2022 (USD Million)
  • TABLE 15. Corticosteroid injection size, by region, 2023 - 2032 (USD Million)
  • TABLE 16. Platelet rich plasma size, by region, 2018 - 2022 (USD Million)
  • TABLE 17. Platelet rich plasma size, by region, 2023- 2032 (USD Million)
  • TABLE 18. Knee size, by region, 2018 - 2022 (USD Million)
  • TABLE 19. Knee size, by region, 2023 - 2032 (USD Million)
  • TABLE 20. Shoulder & elbow size, by region, 2018 - 2022 (USD Million)
  • TABLE 21. Shoulder & elbow size, by region, 2023 - 2032 (USD Million)
  • TABLE 22. Ankle & hip market size, by region, 2018 - 2022 (USD Million)
  • TABLE 23. Ankle & hip market size, by region, 2023 - 2032 (USD Million)
  • TABLE 24. Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 25. Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 26. Hospitals market size, by region, 2018 - 2022 (USD Million)
  • TABLE 27. Hospitals market size, by region, 2023 - 2032 (USD Million)
  • TABLE 28. Clinic market size, by region, 2018 - 2022 (USD Million)
  • TABLE 29. Clinic market size, by region, 2023 - 2032 (USD Million)
  • TABLE 30. Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 31. Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 32. North America Joint Pain Injections Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 33. North America Joint Pain Injections Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 34. North America Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 35. North America Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 36. North America Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 37. North America Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 38. North America Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 39. North America Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 40. U.S. Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 41. U.S. Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 42. U.S. Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 43. U.S. Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 44. U.S. Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 45. U.S. Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 46. Canada Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 47. Canada Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 48. Canada Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 49. Canada Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 50. Canada Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 51. Canada Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 52. Europe Joint Pain Injections Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 53. Europe Joint Pain Injections Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 54. Europe Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 55. Europe Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 56. Europe Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 57. Europe Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 58. Europe Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 59. Europe Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 60. Germany Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 61. Germany Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 62. Germany Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 63. Germany Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 64. Germany Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 65. Germany Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 66. UK Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 67. UK Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 68. UK Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 69. UK Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 70. UK Joint Pain Injections Market size, by plant-based, 2018 - 2022 (USD Million)
  • TABLE 71. UK Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 72. UK Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 73. France Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 74. France Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 75. France Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 76. France Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 77. France Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 78. France Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 79. Spain Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 80. Spain Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 81. Spain Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 82. Spain Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 83. Spain Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 84. Spain Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 85. Italy Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 86. Italy Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 87. Italy Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 88. Italy Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 89. Italy Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 90. Italy Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 91. Asia Pacific Joint Pain Injections Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 92. Asia Pacific Joint Pain Injections Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 93. Asia Pacific Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 94. Asia Pacific Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 95. Asia Pacific Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 96. Asia Pacific Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 97. Asia Pacific Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 98. Asia Pacific Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 99. China Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 100. China Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 101. China Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 102. China Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 103. China Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 104. China Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 105. Japan Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 106. Japan Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 107. Japan Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 108. Japan Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 109. Japan Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 110. Japan Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 111. India Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 112. India Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 113. India Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 114. India Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 115. India Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 116. India Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 117. Australia Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 118. Australia Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 119. Australia Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 120. Australia Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 121. Australia Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 122. Australia Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 123. South Korea Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 124. South Korea Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 125. South Korea Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 126. South Korea Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 127. South Korea Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 128. South Korea Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 129. Latin America Joint Pain Injections Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 130. Latin America Joint Pain Injections Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 131. Latin America Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 132. Latin America Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 133. Latin America Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 134. Latin America Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 135. Latin America Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 136. Latin America Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 137. Brazil Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 138. Brazil Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 139. Brazil Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 140. Brazil Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 141. Million)
  • TABLE 142. Brazil Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 143. Brazil Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 144. Mexico Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 145. Mexico Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 146. Mexico Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 147. Mexico Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 148. Mexico Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 149. Mexico Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 150. Argentina Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 151. Argentina Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 152. Argentina Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 153. Argentina Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 154. Argentina Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 155. Argentina Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 156. MEA Joint Pain Injections Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 157. MEA Joint Pain Injections Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 158. MEA Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 159. MEA Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 160. MEA Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 161. MEA Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 162. MEA Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 163. MEA Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 164. South Africa Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 165. South Africa Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 166. South Africa Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 167. South Africa Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 168. South Africa Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 169. South Africa Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 170. Saudi Arabia Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 171. Saudi Arabia Joint Pain Injections Market size, by injection type, 2023 - 2032 (USD Million)
  • TABLE 172. Saudi Arabia Joint Pain Injections Market size, by joint type, 2018 - 2022 (USD Million)
  • TABLE 173. Saudi Arabia Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 174. Saudi Arabia Joint Pain Injections Market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 175. Saudi Arabia Joint Pain Injections Market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 176. UAE Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 177. UAE Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 178. UAE Joint Pain Injections Market size, by injection type, 2018 - 2022 (USD Million)
  • TABLE 179. UAE Joint Pain Injections Market size, by joint type, 2023 - 2032 (USD Million)
  • TABLE 180. UAE Joint Pain Injections Market size, by end use, 2018 - 2022 (USD Million)
  • TABLE 181. UAE Joint Pain Injections Market size, by end use, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach (supply side analysis)
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Data Validation
  • FIG. 4 Protein supplements industry 360 degree synopsis, 2018-2032
  • FIG. 5 Industry segmentation
  • FIG. 6 Joint Pain Injections Market size, 2018 - 2032 (USD Million)
  • FIG. 7 Growth potential analysis, by injection type
  • FIG. 8 Growth potential analysis, by joint type
  • FIG. 9 Growth potential analysis, by end user
  • FIG. 10 Porter's analysis
  • FIG. 11 Competitive matrix analysis, 2022
  • FIG. 12 PESTEL analysis
  • FIG. 13 Key segment trends, by injection type
  • FIG. 14 Key segment trends, by joint type
  • FIG. 15 Key segment trends, by end-use
  • FIG. 16 Key regional trends
  • FIG. 17 Competitive dashboard, 2022
目次
Product Code: 5403

Joint Pain Injections Market trends are slated to be propelled by 2032 given the elevating demand for knee pain injections worldwide. Knee joint pain injections are deemed to be an ideal product to treat joint pain conditions. A recent evaluation of the Medicare sample database demonstrated that more than 1/3rd of patients with newly identified knee osteoarthritis were treated with at least one intra-articular corticosteroid injection.

Growing demand for joint pain injections for effective and quick treatment of joint inflammation and pain and soft tissue conditions would further strengthen the market outlook over 2023-2032.

Global expansion and product range diversification strategies by prominent market players are slated to have a positive impact on the industry growth. For example, Seikagu launched HyLink in Taiwan. The product is an intra-articular single injection viscosupplement for the treatment of knee osteoarthritis. It has been made of Seikagaku's exceptional crosslinking technology.

The global joint pain injections industry has been bifurcated on the basis of injection type, joint type, end-use, and region.

Considering the injection type, the platelet rich plasma segment is predicted to amass considerable gains through 2032, attributable to its ability to provide optimum relief from pain and swelling and freedom of movement for a longer time. According to a study, the platelet rich plasma injections have depicted promising results in achieving pain reduction and improved function in patients suffering from OA. Besides, the injections also delay the need for knee replacement. Such factors would impel the segmental growth prospects in the ensuing years.

With regard to the joint type, ankle and hip segment would draw massive traction due to the rising incidence rate of ankle and hip arthritis. As per a recent survey, ankle osteoarthritis currently affects 1% of the global population, with an estimated frequency of 30 cases per 100,000 people. Moreover, advancements in joint pain injections that deliver ample benefits in treating ankle and hip joint pain and the launch of new products by prominent companies in the business sphere would potentially drive the market growth between 2023-2032.

Based on the end-use, clinics are estimated to gain major impetus in the global pain injections market fueled by the mounting preference of people for minimally invasive surgical procedures in these settings. Pivotal factors like the availability of a broad range of orthopedic procedures, incorporation of advanced technology for surgeries, and deliverance of high-quality services across clinics would add to the booming market curve. The segmental revenues are projected to surge beyond $2.5 billion by 2032.

Geographically, the sale of joint pain injections is estimated to gain momentum in Europe in the coming years on grounds of the growing healthcare expenditure, increasing geriatric population, and surging OA incidences in the region. The adoption of novel strategies by various central governments to promote access to orthopedic diseases treatments would complement the regional market growth over the review timeline.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data joint types
    • 1.5.1 Secondary
      • 1.5.1.1 Paid joint types
      • 1.5.1.2 Unpaid joint types
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Joint pain injection 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Form trends
    • 2.1.3 Source trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Joint pain injection Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing prevalence of orthopaedic diseases
      • 3.3.1.2 Technological advancements
      • 3.3.1.3 Rising demand for knee pain injections
      • 3.3.1.4 Therapeutics advantages to relieve joint pain & inflammation
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High cost of joint pain injections
      • 3.3.2.2 Side effects associated with joint pain injections
  • 3.4 Growth potential analysis
    • 3.4.1 By injection type
    • 3.4.2 By joint type
    • 3.4.3 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2022
    • 3.7.1 Company matrix analysis, 2022
  • 3.8 PESTEL analysis

Chapter 4 Joint Pain Injections Market, By injection type

  • 4.1 Key segment trends
  • 4.2 Hyaluronic acid injections
    • 4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 4.3 Corticosteroid injections
    • 4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 4.4 Platelet rich plasma injections
    • 4.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 5 Joint Pain Injections Market, By joint type

  • 5.1 Key segment trends
  • 5.2 Knee
    • 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.3 Shoulder & elbow
      • 5.3.1.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.4 Ankle & hip
      • 5.4.1.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.5 Others
      • 5.5.1.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Joint Pain Injections Market, By end use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.3 Clinics
    • 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.4 Others
    • 6.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Joint Pain Injections Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.2.2 Market size, by injection type, 2018 - 2032 (USD Million)
    • 7.2.3 Market size, by joint type, 2018 - 2032 (USD Million)
    • 7.2.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.2.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.2.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.2.5.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.2.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.2.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.2.6.4 Market size, by end use, 2018 - 2032 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.3.2 Market size, by injection type, 2018 - 2032 (USD Million)
    • 7.3.3 Market size, by joint type, 2018 - 2032 (USD Million)
    • 7.3.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.3.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.3.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.3.5.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.3.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.3.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.3.6.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.3.7.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.3.7.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.3.7.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.3.8.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.3.8.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.3.8.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.3.9.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.3.9.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.3.9.4 Market size, by end use, 2018 - 2032 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.4.2 Market size, by injection type, 2018 - 2032 (USD Million)
    • 7.4.3 Market size, by joint type, 2018 - 2032 (USD Million)
    • 7.4.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.4.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.4.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.4.5.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.4.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.4.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.4.6.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.4.7.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.4.7.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.4.7.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.4.8.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.4.8.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.4.8.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.4.9.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.4.9.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.4.9.4 Market size, by end use, 2018 - 2032 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
    • 7.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
    • 7.5.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.5.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.5.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.5.5.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.5.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.5.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.5.6.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.5.7.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.5.7.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.5.7.4 Market size, by end use, 2018 - 2032 (USD Million)
  • 7.6 Middle East and Africa
    • 7.6.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
    • 7.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
    • 7.6.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.6.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.6.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.6.5.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.6.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.6.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.6.6.4 Market size, by end use, 2018 - 2032 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by country, 2018 - 2032 (USD Million)
      • 7.6.7.2 Market size, by injection type, 2018 - 2032 (USD Million)
      • 7.6.7.3 Market size, by joint type, 2018 - 2032 (USD Million)
      • 7.6.7.4 Market size, by end use, 2018 - 2032 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2022
  • 8.2 Zimmer Biomet
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Anika Therapeutics, Inc.
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Bioventus
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Sanofi
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Pacira BioSciences (Flexion)
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 OrthogenRx
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Pfizer
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Ferring B.V.
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Lifecore Biomedical
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Wright Medical Group (Stryker)
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Stryker
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 9.12. Emcyte Corporation
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Arthrex
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis